ROBERT KEITH NAVIAUX, M.D., PH.D.
Medical Practice in San Diego, CA
License number
California G61267
Category
Medical Practice
Type
Medical Genetics, Ph.D. Medical Genetics
Address
Address
214 Dickinson Street Bldg Ctf ROOM C103, San Diego, CA 92103
Phone
(619) 543-2904
(619) 543-7868 (Fax)
(619) 543-7868 (Fax)
Personal information
See more information about ROBERT KEITH NAVIAUX at radaris.comName
Address
Phone
11084 Viacha Dr, San Diego, CA 92124
11084 Viacha Ct, San Diego, CA 92124
11760 Calamar Dr, San Diego, CA 92124
Professional information
Associate Professor At University Of California, San Diego
Location:
Greater San Diego Area
Industry:
Research
Experience:
University of California, San Diego (Research industry): Associate Professor, (-)
Dr. Robert K Naviaux, San Diego CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
214 Dickinson St SUITE C103, San Diego 92103
(619) 543-2904 (Phone), (619) 543-7868 (Fax)
(619) 543-2904 (Phone), (619) 543-7868 (Fax)
Certifications:
Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Indiana University / School of Medicine
Graduated: 1986
Uc-Davis
Indiana University / School of Medicine
Graduated: 1986
Uc-Davis
Methods For Diagnosing And Assessing Kidney Disease
US Patent:
2013027, Oct 24, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/843680
Inventors:
Robert NAVIAUX - San Diego CA, US
International Classification:
G01N 33/48, H01J 49/26, G01N 30/00
US Classification:
73 2335, 73 3105, 250282
Abstract:
The technology relates in part to methods for identifying the presence of kidney disease, determining the level of kidney disease, or the progression of kidney disease, in a subject that has or has not been diagnosed with diabetes. The technology further relates to methods for determining the targets for therapy for kidney disease, the efficacy of a treatment for kidney disease, and methods for determining the toxicity of a therapeutic in a subject with kidney disease. The technology relates in part to methods for identifying the presence of kidney disease, determining the level of kidney disease, or the progression of kidney disease, in a subject that has or has not been diagnosed with diabetes. The technology further relates to methods for determining the targets for therapy for kidney disease, the efficacy of a treatment for kidney disease, and methods for determining the toxicity of a therapeutic in a subject with kidney disease.
Method Of Treatment Of Mitochondrial Disorders
US Patent:
7638501, Dec 29, 2009
Filed:
Feb 23, 2000
Appl. No.:
09/889251
Inventors:
Robert K. Naviaux - San Diego CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/7072
US Classification:
514 50, 514 45
Abstract:
In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
Methods Of Treatment Of Mitochondrial Disorders
US Patent:
2004022, Nov 11, 2004
Filed:
Jun 14, 2004
Appl. No.:
10/868717
Inventors:
Robert Naviaux - San Diego CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
International Classification:
A61K031/7072
US Classification:
514/050000
Abstract:
In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
Methods Of Treatment Of Mitochondrial Disorders
US Patent:
2010009, Apr 22, 2010
Filed:
Dec 21, 2009
Appl. No.:
12/643920
Inventors:
Robert K. Naviaux - San Diego CA, US
International Classification:
A61K 31/7064, A61P 43/00, A61K 31/122
US Classification:
424 941, 514 49
Abstract:
In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.